CAS RN: 622-31-1
α-Benzaldoxime
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
90% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20251023
5g / 25g / 100g / 500g
Confirm by inquiry
Shanghai, Shandong 8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 100g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 622-31-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
100g
≥97%
0
Out of Stock
Hong Kong
Inquiry
622-31-1 / N-benzylidenehydroxylamine
Standard CAS: 622-31-1
Multi CAS: Yes
Basic Information
copy
CAS
622-31-1 copy
Multi CAS
Yes copy
Molecular Formula
C7H7NO copy
Molecular Weight
121.140000 copy
Exact Mass
121.052764 copy
InChI
InChI=1S/C7H7NO/c9-8-6-7-4-2-1-3-5-7/h1-6,9H copy
InChIKey
VTWKXBJHBHYJBI-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Aromatic heavy atom count
6 copy
Rotatable bonds
1 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
35.82 copy
TPSA
32.59 copy
LogP / Solubility
WLOGP
1.49 copy
MLOGP
1.31 copy
XLogP3
1.9 copy
Consensus LogP
1.57 copy
Log S (ESOL)
-1.96 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.63 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.81 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.4 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy